Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA advisory panel votes against new use of AbbVie's Humira
FDA advisory panel votes against new use of AbbVie's Humira
FDA advisory panel votes against new use of AbbVie's Humira
Submitted by
admin
on July 24, 2013 - 9:51am
Source:
Reuters
News Tags:
FDA
advisory panels
AbbVie
Humira
spondyloarthritis
Headline:
FDA advisory panel votes against new use of AbbVie's Humira
Do Not Allow Advertisers to Use My Personal information
